EXAS: the cash flow

Cash Flow Overview

Change in Cash

$349,360K

Free Cash flow

$356,782K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-12-31

Net loss

-207,949

Depreciation

124,879

Equity securities, fv-ni, gain (loss)

3,081

Deferred tax benefit

-1,544

Share-based payment arrangement, noncash expense

217,666

Gain on settlements of convertible notes, net

Amortization of intangible assets

96,700

Impairment of long-lived and indefinite-lived assets

7,200

Research and development asset acquired in transaction other than business combination or joint venture formation, writeoff

75,000

Gain (loss) on contingent consideration from disposition of asset

Business combination, contingent consideration arrangements, change in amount of contingent consideration, liability

26,806

Non-cash lease expense

27,040

Other noncash income (expense)

-6,896

Accounts receivable, net

48,891

Inventory, net

3,772

Operating lease liabilities

-28,541

Accounts payable and accrued liabilities

214,042

Increase (decrease) in other operating assets

5,794

Increase (decrease) in other operating liabilities

-5,219

Net cash provided by operating activities

491,438

Purchases of marketable securities

140,269

Maturities and sales of marketable securities

572,277

Purchases of property, plant and equipment

134,656

Proceeds from contingent consideration receivable

27,971

Proceeds from sale of investments in privately-held companies

Payments to acquire other investments

55,499

Business combination, net of cash acquired and issuance costs

Asset acquisitions, net of cash acquired

75,000

Other investing activities

-297

Net cash provided by (used in) investing activities

195,121

Proceeds, issuance of shares, share-based payment arrangement, including option exercised

1,902

Proceeds in connection with the company's employee stock purchase plan

26,544

Proceeds from issuance of convertible notes

Repayments of accounts receivable securitization

Repayments of convertible debt

249,172

Payment, tax withholding, share-based payment arrangement

86,477

Payment for contingent consideration liability, financing activities

19,000

Other financing activities

-11,887

Net cash provided by (used in) financing activities

-338,090

Effects of exchange rate changes on cash and cash equivalents

891

Net increase (decrease) in cash, cash equivalents, and restricted cash

349,360

Cash and cash equivalents at beginning of period

606,636

Cash and cash equivalents at end of period

955,996

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow Overview

Change in Cash

$349,360K

Free Cash flow

$356,782K

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2025-12-31

Net loss

-207,949

Depreciation

124,879

Equity securities, fv-ni, gain (loss)

3,081

Deferred tax benefit

-1,544

Share-based payment arrangement, noncash expense

217,666

Gain on settlements of convertible notes, net

Amortization of intangible assets

96,700

Impairment of long-lived and indefinite-lived assets

7,200

Research and development asset acquired in transaction other than business combination or joint venture formation, writeoff

75,000

Gain (loss) on contingent consideration from disposition of asset

Business combination, contingent consideration arrangements, change in amount of contingent consideration, liability

26,806

Non-cash lease expense

27,040

Other noncash income (expense)

-6,896

Accounts receivable, net

48,891

Inventory, net

3,772

Operating lease liabilities

-28,541

Accounts payable and accrued liabilities

214,042

Increase (decrease) in other operating assets

5,794

Increase (decrease) in other operating liabilities

-5,219

Net cash provided by operating activities

491,438

Purchases of marketable securities

140,269

Maturities and sales of marketable securities

572,277

Purchases of property, plant and equipment

134,656

Proceeds from contingent consideration receivable

27,971

Proceeds from sale of investments in privately-held companies

Payments to acquire other investments

55,499

Business combination, net of cash acquired and issuance costs

Asset acquisitions, net of cash acquired

75,000

Other investing activities

-297

Net cash provided by (used in) investing activities

195,121

Proceeds, issuance of shares, share-based payment arrangement, including option exercised

1,902

Proceeds in connection with the company's employee stock purchase plan

26,544

Proceeds from issuance of convertible notes

Repayments of accounts receivable securitization

Repayments of convertible debt

249,172

Payment, tax withholding, share-based payment arrangement

86,477

Payment for contingent consideration liability, financing activities

19,000

Other financing activities

-11,887

Net cash provided by (used in) financing activities

-338,090

Effects of exchange rate changes on cash and cash equivalents

891

Net increase (decrease) in cash, cash equivalents, and restricted cash

349,360

Cash and cash equivalents at beginning of period

606,636

Cash and cash equivalents at end of period

955,996

Time Plot

Show the time plot by selecting a row from the table.